The question sounds simple. The answer is still being written. For decades, menopause held a quiet place in public conversation and, all too often, in the consultation itself: a stage that arrived, was recognized by its most visible symptoms and moved on, without anyone asking which woman, exactly, it was arriving in. Between the final menstrual period and the fullness of adult life, some 30 million Brazilian women cross the most decisive hormonal transition of female maturity, each with her own biological terrain, her own history, her own geography. And many of them still leave the consultation with the sense that what they feel belongs to their age, and not to a diagnosis. That is the cost of silence.
"It is your age" is not an answer. It is the starting point of a better question.
MYPAUSA was born from that question. Not from a commercial agenda, not from an imported trend, but from something observed in the consulting room, in the active listening of each woman: Brazil did not yet know its own menopause. The science guiding prescription was sound, but it had been built with little representation of Brazilian women, in populations with a different genetic mix, a different climate, a different reality of access and a different health system. The Brazilian piece of that knowledge was missing. What was missing was the anamnesis of belonging: the one that asks where a woman comes from before deciding what to prescribe for her.
It was to answer that question that MYPAUSA gave the name intelligent prescribing to the reasoning that already lives in good Brazilian clinical practice and needed only a name and a method: to begin from each woman's biological terrain, to recognize the country she carries within her, and to choose the treatment that fits her story. Because Brazil's menopauses are plural, regional, ethnic, social, singular. 5 regions, 27 states, 1 continental country, and a single DNA: Brazilian.
Intelligent prescribing is not a ready-made recipe. It is clinical reasoning with a Brazilian accent.
There is no such thing as the Brazilian woman's menopause. There are the menopauses of Brazilian women.
What began as a clinician's unease became a method, and the method became a network. Today, more than 1,000 physicians trained by MYPAUSA, present in all 27 states, share the same way of reasoning: one that begins with the woman sitting in front of them before any decision about what to prescribe.
Congresses, Summits, mentorships. EMBRACE, Brazil's first national menopause registry (NCT07005648), under way in all 27 states. Brazilian science selected for presentation at the World Congress of the International Menopause Society and debated in the Federal Senate. Each front has its own page on this site. All of them answer the same question.
Reform is not rupture. It is rebuilding on foundations that already exist. Women's health in Brazil has physicians of excellence, a public health system of continental reach and scientific societies respected around the world. What was missing was a thread to stitch all of this together around menopause. MYPAUSA is that thread, on 4 fronts:
Training those who prescribe.
Producing evidence with an accent.
Bringing information where it has not yet arrived.
Turning knowledge into public policy.
That no woman in Brazil reaches the second half of her life without having been heard. That every Brazilian physician recognizes menopause when it walks into the consulting room, even when it does not announce its name. That the world looks to Brazil when it wants to understand the menopause of a plural country.
A draft of a legacy written across 5 great regions within a single DNA, for 30 million real women, with names, routines and histories.
Brazilian menopause has an accent.
Source: IBGE, Population Projections, 2024 revision. Women aged 40 to 65, 2026 reference year.
Physician and researcher · CRM-SP 151.126
Architect of the EMBRACE study, Brazil's first national menopause registry.
There is a question Fabiane Berta has asked since the beginning of her clinical career: who is menopause in Brazil? She chose to build the answer with method, and that construction is called MYPAUSA.
She came to the climacteric through listening. The consulting room revealed what the textbooks did not yet hold: women returning from other appointments with the same silence and the same prescription that failed to recognize them. That is where clinical practice became a research question.
At the Federal University of São Paulo (UNIFESP), under the supervision of Prof. Ivaldo Silva, MD, PhD, and with the participation of the Science Valley Research Institute, her master's dissertation screened for depression in 15,734 Brazilian women and showed that prevalence does not change between the reproductive years and postmenopause, but treatment does: more medication, less psychotherapy, and a different burden in each region of the country. The work was selected for oral presentation at the 2026 World Congress of the International Menopause Society in Rio de Janeiro. She is now pursuing her doctorate at the same institution, under the same supervision, with the EMBRACE São Paulo Cohort, a single-center subset of the national registry.
She is the architect of EMBRACE (MYPAUSA), a national registry active in all 27 states and coordinated by Science Valley, created to drive a national reform of women's health that ensures access to innovation and up-to-date treatment, influences public and private policy, and respects the regional diversity and the many ways of being a woman in Brazil. She is a co-author of clinical trials and population-based studies published in international journals, among them Menopause and Annals of Medicine, and co-authored with legislative consultant Clarita Costa Maia the Federal Senate study "Mudaram as Estações" ("The Seasons Have Changed"), which brought menopause into the public policy debate. Her complete scientific output, with registrations and publications, is on the Research page.
She founded the Fabiane Berta Institute, where intelligent prescribing is daily practice, and MYPAUSA, today a movement of more than 1,000 physicians trained for the reform of women's health in Brazil. She is the author of the concept that signs every word of that movement: Brazilian menopause has an accent.
Training
Obstetrics and Gynecology, Santa Casa de São Paulo (FCMSCSP)
Fetal Medicine (FCMSCSP)
Gynecological Endocrinology (FCMSCSP)
Postgraduate studies in Endocrinology, Neuroscience and Behavior*
Academic degrees
Master of Science in Gynecology, UNIFESP/EPM
Doctoral candidate, Department of Gynecology, UNIFESP/EPM
Thesis: EMBRACE São Paulo Cohort, a subset of the national menopause registry
Research
Principal Investigator and Chair of the Steering Committee, EMBRACE (MYPAUSA) study, coordinated by the Science Valley Research Institute (ClinicalTrials.gov NCT07005648)
Scientific and institutional roles
International Menopause Society (IMS) Clinical Colloquium 2026, Committee Member
Member, Young Physicians Committee, CREMESP (Regional Medical Council of the State of São Paulo)
Science Medical Team, OB-GYN Specialist | Investigator, Key Opinion Leader, Fagron Brasil
*Under CFM Resolution 2,336/2023 (Brazilian Federal Council of Medicine): not a board-certified specialist.
First read at the opening of the 3rd MYPAUSA Congress, May 2026. Presented in its original Portuguese.
Thousands of physicians who chose to answer it.
MYPAUSA · 1st edition
MYPAUSA · 2nd edition
MYPAUSA · 3rd edition